Ella Zomer Selected Research

Ella Zomer Research Topics

Disease

19	Cardiovascular Diseases (Cardiovascular Disease) 10/2022 - 05/2012
5	Hypertension (High Blood Pressure) 07/2022 - 05/2012
4	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 01/2023 - 11/2020
4	Heart Failure 01/2021 - 01/2019
3	Stroke (Strokes) 07/2022 - 11/2018
3	Type 2 Diabetes Mellitus (MODY) 07/2022 - 01/2021
3	Neoplasms (Cancer) 01/2022 - 01/2018
3	Myocardial Infarction 07/2020 - 01/2019
2	Coronary Disease (Coronary Heart Disease) 01/2023 - 07/2022
2	Disease Progression 01/2022 - 11/2020
2	Dementia (Dementias) 12/2018 - 01/2018
2	Metabolic Syndrome (Dysmetabolic Syndrome X) 04/2013 - 05/2012
1	Chest Pain (Chest Pains) 01/2023
1	Heart Diseases (Heart Disease) 07/2022
1	Dyslipidemias (Dyslipidemia) 07/2022
1	Obesity 01/2022
1	Acute Coronary Syndrome 10/2021
1	Kidney Diseases (Kidney Disease) 04/2021
1	Migraine Disorders (Migraine) 11/2020
1	Knee Osteoarthritis 02/2019
1	Frailty 01/2019
1	Carotid Artery Diseases 01/2019
1	Pain (Aches) 01/2019
1	Thrombosis (Thrombus) 01/2019
1	Peripheral Arterial Disease 01/2019
1	Vascular Diseases (Vascular Disease) 11/2018
1	Hip Osteoarthritis (Coxarthrosis) 01/2018
1	Developmental Dysplasia of the Hip 01/2018
1	Premature Birth (Birth, Premature) 01/2018
1	Osteophyte 01/2018
1	Mental Disorders (Mental Disorder) 02/2016
1	Diabetes Mellitus 04/2013
1	Liver Diseases (Liver Disease) 01/2008

Drug/Important Bio-Agent (IBA)

13	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2023 - 11/2012
5	LipidsIBA 01/2023 - 10/2019
3	oxidized low density lipoproteinIBA 01/2023 - 07/2022
3	Glucose (Dextrose)FDA LinkGeneric 01/2023 - 11/2020
3	Guanosine Diphosphate (GDP)IBA 01/2022 - 01/2021
3	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2019 - 04/2013
2	Insulin (Novolin)FDA Link 01/2023 - 11/2020
2	LDL CholesterolIBA 07/2022 - 11/2020
2	sacubitril and valsartan sodium hydrate drug combinationIBA 01/2021 - 09/2020
2	RivaroxabanIBA 01/2019 - 11/2018
2	CholesterolIBA 02/2016 - 05/2012
2	Antihypertensive Agents (Antihypertensives)IBA 04/2013 - 05/2012
1	TroponinIBA 01/2023
1	CarnosineIBA 01/2022
1	Brain Natriuretic Peptide (Natrecor)FDA Link 01/2021
1	eicosapentaenoic acid ethyl esterIBA 01/2021
1	antineoplaston A10 (A 10)IBA 01/2021
1	pro-brain natriuretic peptide (1-76)IBA 01/2021
1	Enalapril FDA LinkGeneric 01/2021
1	dapagliflozinIBA 01/2021
1	imazodanIBA 11/2020
1	Adenosine Triphosphate (ATP)IBA 11/2020
1	8- hydroxy- 2,2,14,14- tetramethylpentadecanedioic acidIBA 11/2020
1	citrate (pro-3S)-lyaseIBA 11/2020
1	Angiotensin Receptors (Angiotensin II Receptor)IBA 09/2020
1	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 09/2020
1	Neprilysin (Neutral Endopeptidase)IBA 09/2020
1	Angiotensin Receptor AntagonistsIBA 09/2020
1	Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA 09/2020
1	ALN-PCSIBA 01/2020
1	C-Reactive ProteinIBA 01/2019
1	AnticoagulantsIBA 01/2019
1	canakinumab FDA Link 01/2019
1	Vitamin D FDA LinkGeneric 06/2015
1	AcidsIBA 04/2013
1	urotensin IIIBA 01/2008

Therapy/Procedure

13	Therapeutics 01/2023 - 05/2012
3	Secondary Prevention 10/2022 - 01/2019
1	Percutaneous Coronary Intervention 10/2021
1	CARE protocol 08/2021
1	Injections 11/2020
1	Patient Readmission 07/2020
1	Replacement Arthroplasty 02/2019
1	Complementary Therapies (Alternative Medicine) 01/2019
1	Length of Stay 11/2018
1	Denervation 11/2018
1	Hip Replacement Arthroplasty (Total Hip Replacement) 01/2018
1	Combination Drug Therapy (Combination Chemotherapy) 04/2013